Contemporary Approach to Electrical and Pharmacological Cardioversion of Atrial Fibrillation

References

• . Go AS, Hylek EM, Phillips KA, . Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285(18):2370–2375
   PubMed Web of Science ®Google Scholar
• . Fuster V, Rydén LE, Cannom DS, . 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol. 2011;57(11):e101–e198
   PubMed Web of Science ®Google Scholar
• . Gallagher MM, Guo XH, Poloniecki JD, . Initial energy setting, outcome and efficiency in direct current cardioversion of atrial fibrillation and flutter. J Am Coll Cardiol. 2001;38:1498–1504
   PubMed Web of Science ®Google Scholar
• . Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 1995;92(7):1954–1968
   PubMed Web of Science ®Google Scholar
• . Canessa R, Lema G, Urzúa J, Dagnino JConcha M. Anesthesia for elective cardioversion: a comparison of four anesthetic agents. J Cardiothorac Vasc Anesth. 1991;5(6):566–568
   Google Scholar
• . Stoneham MD. Anaesthesia for cardioversion. Anaesthesia. 1996;51(6):565–570
   Google Scholar
• . Mittal S, Ayati S, Stein KM, . Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks. Circulation. 2000;101(11):1282–1287
   Google Scholar
• . Page RL, Kerber RE, Russell JK, ; BiCard Investigators. Biphasic versus monophasic shock waveform for conversion of atrial fibrillation: the results of an international randomized, double-blind multicenter trial. J Am Coll Cardiol. 2002;39(12):1956–1963
   Google Scholar
• . Lévy S, Lauribe P, Doha E, . Arandomized comparison of external and internal cardioversion of chronic atrial fibrillation. Circulation. 1992;86(5):1415–1420
   Google Scholar
• . Ozdemir M, Türkoglu S, Kaya MG, Cengel A. Prospective randomized trial of transthoracic versus low-energy internal cardioversion in persistent atrial fibrillation: long term follow-up. Int Heart J. 2006;47(5):753–762
   Google Scholar
• . Kirchhof P, Eckardt L, Loh P, . Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial. Lancet. 2002;360(9342):1275–1279
   Google Scholar
• . Botto GL, Politi A, Bonini W, Broffoni T, Bonatti R. External cardioversion of atrial fibrillation: role of paddle position on technical efficacy and energy requirements. Heart. 1999;82(6):726–730
   Google Scholar
• . Mathew TP, Moore A, McIntyre M, . Randomised comparison of electrode positions for cardioversion of atrial fibrillation. Heart. 1999;81(6):576–579
   Google Scholar
• . Kerber RE, Grayzel J, Hoyt R, Marcus M, Kennedy J. Transthoracic resistance in human defibrillation. Influence of body weight, chest size, serial shocks, paddle size and paddle contact pressure. Circulation. 1981;63(3):676–682
   Google Scholar
• . Kerber RE. Transthoracic cardioversion of atrial fibrillation and flutter: standard techniques and new advances. Am J Cardiol. 1996;78(8A):22–26
   Google Scholar
• . Fatkin D, Kelly RP, Feneley MP. Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. J Am Coll Cardiol. 1994;23(4):961–969
   PubMed Web of Science ®Google Scholar
• . Thambidorai SK, Parakh K, Martin DO, . Relation of C-reactive protein correlates with risk of thromboembolism in patients with atrial fibrillation. Am J Cardiol. 2004;94(6):805–807
   Web of Science ®Google Scholar
• . Berger M, Schweitzer P. Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: a retrospective analysis. Am J Cardiol. 1998;82(12):1545–1547
   PubMed Web of Science ®Google Scholar
• . Khan IA. Atrial stunning: determinants and cellular mechanisms. Am Heart J. 2003;145(5):787–794
   Google Scholar
• . Manning WJ, Leeman DE, Gotch PJ, Come PC. Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation. J Am Coll Cardiol. 1989;13(3):617–623
   Google Scholar
• . Grimm RA, Stewart WJ, Maloney JD, . Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: characterization by simultaneous transesophageal echocardiography. J Am Coll Cardiol. 1993;22(5):1359–1366
   PubMed Web of Science ®Google Scholar
• . Black IW, Fatkin D, Sagar KB, . Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation, a multicenter study. Circulation. 1994;89(6):2509–2513
   Google Scholar
• . Mattioli AV, Castelli A, Bastia E, Mattioli G. Atrial ejection force in patients with atrial fibrillation: comparison between DC shock and pharmacological cardioversion. Pacing Clin Electrophysiol. 1999;22(1 pt 1):33–38
   Google Scholar
• . Stellbrink C, Nixdorff U, Hofmann T, ; ACE (Anticoagulation in Cardioversion using Enoxaparin) Study Group. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial. Circulation. 2004;109(8):997–1003
   Google Scholar
• . Klein AL, Jasper SE, Katz WE, ; ACUTE II Steering and Publications Committee for the ACUTE II Investigators. The use of enoxaparin compared with unfractionated heparin for short-term antithrombotic therapy in atrial fibrillation patients undergoing transoesophageal echocardiography-guided cardioversion: assessment of Cardioversion Using Transoesophageal Echocardiography (ACUTE) II randomized multicentre study. Eur Heart J. 2006;27(23):2858–2865
   PubMed Web of Science ®Google Scholar
• . Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001;285(22):2864–2870
   PubMed Web of Science ®Google Scholar
• . Olesen JB, Lip GY, Hansen ML, . Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ. 2011;342:d124
   PubMed Web of Science ®Google Scholar
• . Nagarakanti R, Ezekowitz MD, Oldgren J, . Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion. Circulation. 2011;123(2):131–136
   PubMed Web of Science ®Google Scholar
• . Ryman J, Frick M, Frykman V, Rosenqvist M. Duration of warfarin sodium therapy prior to electrical cardioversion of atrial fibrillation. J Intern Med. 2003;253:76–80
   PubMed Web of Science ®Google Scholar
• . Lund M, French JK, Johnson RN, Williams BF, White HD. Serum troponins T and I after elective cardioversion. Eur Heart J. 2000;21(3):245–253
   Google Scholar
• . Greaves K, Crake T. Cardiac troponin T does not increase after electrical cardioversion for atrial fibrillation or atrial flutter. Heart. 1998;80(3):226–228
   Google Scholar
• . Ambler JJ, Deakin CD. A randomised controlled trial of the effect of biphasic or monophasic waveform on the incidence and severity of cutaneous burns following external direct current cardioversion. Resuscitation. 2006;71(3):293–300
   Google Scholar
• . Page RL. Treatment of arrhythmias in pregnancy. Am Heart J. 1995;130(4):871–876
   PubMed Web of Science ®Google Scholar
• . Ogburn PL Jr, Schmidt G, Linman J, Cefalo RC. Paroxysmal tachycardia and cardioversion during pregnancy. J Reprod Med. 1992;27(6):359–366
   Google Scholar
• . Finlay AY, Edmonds V.D.C. cardioversion in pregnancy. Br J Clin Pract. 1979;33:88–94
   Google Scholar
• . Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO; American College of Chest Physicians. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141( 2 suppl): e691S–e736S
   PubMed Web of Science ®Google Scholar
• . Levine PA, Barold S, Fletcher RD, Talbot P. Adverse acute and chronic effects of electrical defibrillation and cardioversion on implanted unipolar cardiac pacing systems. J Am Coll Cardiol. 1983;1(6):1413–1422
   Google Scholar
• . Manegold JC, Israel CW, Ehrlich JR, . External cardioversion of atrial fibrillation in patients with implanted pacemaker or cardioverter-defibrillator systems: a randomized comparison of monophasic and biphasic shock energy application. Eur Heart J. 2007;28(14):1731–1738
   Google Scholar
• . Oral H, Ozaydin M, Sticherling C, . Effect of atrial fibrillation duration on probability of immediate recurrence after transthoracic cardioversion. J Cardiovasc Electrophysiol. 2003;14(2):182–185
   Google Scholar
• . Chugh A, Ozaydin M, Scharf C, . Mechanism of immediate recurrences of atrial fibrillation after restoration of sinus rhythm. Pacing Clin Electrophysiol. 2004;27(1):77–82
   Google Scholar
• . Timmermans C, Rodriguez LM, Smeets JL, Wellens HJ. Immediate reinitiation of atrial fibrillation following internal atrial defibrillation. J Cardiovasc Electrophysiol. 1998;9(2):122–128
   Google Scholar
• . Tieleman RG, Van Gelder IC, Crijns HJ, . Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria? J Am Coll Cardiol. 1998;31(1):167–173
   Google Scholar
• . Di Benedetto S. Quinidine versus propafenone for conversion of atrial fibrillation to sinus rhythm. Am J Cardiol. 1997;80(4):518–519
   Google Scholar
• . Kochiadakis GE, Igoumenidis NE, Hamilos ME, Marketou ME, Chlouverakis GI, Vardas PE. A comparative study of the efficacy and safety of procainamide versus propafenone versus amiodarone for the conversion of recent-onset atrial fibrillation. Am J Cardiol. 2007;99(12):1721–1725
   Google Scholar
• . Stroobandt R, Stiels B, Hoebrechts R. Propafenone for conversion and prophylaxis of atrial fibrillation. Propafenone Atrial Fibrillation Trial Investigators. Am J Cardiol. 1997;79(4):418–423
   Google Scholar
• . Martinez—Marcos FJ, García—Garmendia JL, Ortega—Carpio A, Fernández—Gómez JM, Santos JM, Camacho C. Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm. Am J Cardiol. 2000;86(9):950–953
   PubMed Web of Science ®Google Scholar
• . Fresco P, Proclemer A, Pavan A, . Intravenous propafenone in paroxysmal atrial fibrillation: a randomized, placebo-controlled, double-blind multicenter clinical trial. Paroxysmal Atrial Fibrillation Italian Trial (PAFIT)-2 Investigators. Clin Cardiol. 1996;19(5):409–412
   Google Scholar
• . Reisinger J, Gatterer E, Lang W, . Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset. Eur Heart J. 2004;25(15):1318–1324
   Google Scholar
• . Madrid AH, Moro C, Marín—Huerta E, Mestre JL, Novo L, Costa A. Comparison of flecainide and procainamide in cardioversion of atrial fibrillation. Eur Heart J. 1993;14(8):1127–1131
   Google Scholar
• . Stambler BS, Wood MA, Ellenbogen KA, Perry KT, Wakefield LK, VanderLugt JT. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators. Circulation. 1996;94(7):1613–1621
   PubMed Web of Science ®Google Scholar
• . Volgman AS, Carberry PA, Stambler B, . Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation. J Am Coll Cardiol. 1998;31(6):1414–1419
   PubMed Web of Science ®Google Scholar
• . Hohnloser SH, van de Loo A, Baedeker F. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine. J Am Coll Cardiol. 1995;26(4):852–858
   Google Scholar
• . Halinen MO, Huttunen M, Paakkinen S, Tarssanen L. Comparison of Sotalol with digoxin-quinidine for conversion of acute atrial fibrillation to sinus rhythm (the Sotalol-Digoxin-Quinidine Trial). Am J Cardiol. 1995;76(7):495–498
   PubMedGoogle Scholar
• . Singh BN, Singh SN, Reda DJ, ; Sotalol Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T) Investigators. Amiodarone versus Sotalol for atrial fibrillation. N Engl J Med. 2005;352(18):1861–1872
   PubMed Web of Science ®Google Scholar
• . Blanc JJ, Voinov C, Maarek M. Comparison of oral loading dose of propafenone and amiodarone for converting recent-onset atrial fibrillation. PARSIFAL Study Group. Am J Cardiol. 1999;84(9):1029–1032
   PubMed Web of Science ®Google Scholar
• . Singh S, Zoble RG, Yellen L, . Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study. Circulation. 2000;102(19):2385–2390
   PubMed Web of Science ®Google Scholar
• . Pedersen OD, Bagger H, Keller N, Marchant B, Køber L, Torp—Pedersen C. Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (DIAMOND) substudy Circulation. 2001;104(3):292–296
   PubMed Web of Science ®Google Scholar
• . Camm AJ, Capucci A, Hohnloser SH, ; AVRO Investigators. Arandomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation. J Am Coll Cardiol. 2011;57(3):313–321
   PubMed Web of Science ®Google Scholar
• . Roy D, Pratt CM, Torp—Pedersen C, ; Atrial Arrhythmia Conversion Trial Investigators. Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial. Circulation. 2008;117(12):1518–1525
   PubMed Web of Science ®Google Scholar
• . Le Heuzey JY, De Ferrari GM, Radzik D, Santini M, Zhu J, Davy JM. A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study. J Cardiovasc Electrophysiol. 2010;21(6):597–605
   PubMed Web of Science ®Google Scholar
• . VanderLugt JT, Mattioni T, Denker S, . Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery. Circulation. 1999;100(4):369–365
   Google Scholar
• . Alboni P, Botto GL, Baldi N, . Outpatient treatment of recent-onset atrial fibrillation with the “pill-in-the-pocket” approach. N Engl J Med. 2004;351(23):2384–2391
   PubMed Web of Science ®Google Scholar
• . Galve E, Rius T, Ballester R, . Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study. J Am Coll Cardiol. 1996;27(5):1079–1082
   PubMed Web of Science ®Google Scholar
• . Singh SN, Fletcher RD, Fisher SG, . Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med. 1995;333(2):77–82
   PubMed Web of Science ®Google Scholar
• . Oral H, Souza JJ, Michaud GF, . Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment. N Engl J Med. 1999:340(24):1849–1854
   PubMedGoogle Scholar
• . Bianconi L, Mennuni M, Lukic V, Castro A, Chieffi M, Santini M. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study. J Am Coll Cardiol. 1996;28(3):700–706
   Google Scholar
• . Boriani G, Biffi M, Capucci A, . Favorable effects of flecainide in transvenous internal cardioversion of atrial fibrillation. J Am Coll Cardiol. 1999;33(2):333–341
   Google Scholar
• . Climent VE, Marin F, Mainar L, . Effects of pretreatment with intravenous flecainide on efficacy of external cardioversion of persistent atrial fibrillation. Pacing Clin Electrophysiol. 2004;27(3):368–372
   Google Scholar
• . Van Noord T, Van Gelder IC, Schoonderwoerd BACrijns HJ. Immediate reinitiation of atrial fibrillation after electrical cardioversion predicts subsequent pharmacologic and electrical conversion to sinus rhythm on amiodarone. Am J Cardiol. 2000;86(12): 1384–1385
   Google Scholar
• . Opolski G, Stanisławska J, Górecki A, Swiecicka G, Torbicki A, Kraska T. Amiodarone in restoration and maintenance of sinus rhythm in patients with chronic atrial fibrillation after unsuccessful direct-current cardioversion. Clin Cardiol. 1997;20(4):337–340
   Google Scholar
• . Kanoupakis EM, Manios EG, Mavrakis HE, Tzerakis PG, Mouloudi HK, Vardas PE. Comparative effects of carvedilol and amiodarone on conversion and recurrence rates of persistent atrial fibrillation. Am J Cardiol. 2004;94(5):659–662
   Google Scholar
• . Tse HF, Lau CP, Ayers GM. Incidence and modes of onset of early reinitiation of atrial fibrillation after successful internal cardioversion, and its prevention by intravenous Sotalol. Heart. 1999;82(3):319–324
   Google Scholar
• . Frick M, Darpö B, Ostergren J, Rosenqvist M. The effect of oral magnesium, alone or as adjuvant to Sotalol, after cardioversion in patients with persistent atrial fibrillation. Eur Heart J. 2000;21(14):1177–1185
   Google Scholar
• . Rossi M, Lown B. The use of quinidine in cardioversion. Am J Cardiol. 1967;19(2):234–238
   PubMedGoogle Scholar
• . Rasmussen K, Wang H, Fausa D. Comparative efficiency of quinidine and verapamil in the maintenance of sinus rhythm after DC conversion of atrial fibrillation. A controlled clinical trial. Acta Med Scand Suppl. 1981;645:23–28
   Google Scholar
• . Jacobs LO, Andrews TC, Pederson DN, Donovan DJ. Effect of intravenous procainamide on direct-current cardioversion of atrial fibrillation. Am J Cardiol. 1998;82(2):241–242
   Google Scholar
• . Lundström T, Rydén L. Chronic atrial fibrillation. Long-term results of direct current conversion. Acta Med Scand. 1988;223(1):53–59
   Google Scholar
• . AFFIRM First Antiarrhythmic Drug Substudy Investigators. Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug. J Am Coll Cardiol. 2003;42(1):20–29
   Google Scholar
• . Wann LS, Curtis AB, January CT, ; ACCF/AHA/HRS. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2011;57(2):223–242
   PubMed Web of Science ®Google Scholar
• . Wilber DJ, Pappone C, Neuzil P, ; ThermoCool AF Trial Investigators. Comparison of antiarrhythmic drug therapy and radio frequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA. 2010;303(4):333–340
   PubMed Web of Science ®Google Scholar